Shore Capital Partners, a healthcare-focused private equity firm, today announced the sale of ClearPath Diagnostics , a leading provider of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE